NMOSD
Clinical trials for NMOSD explained in plain language.
Never miss a new study
Get alerted when new NMOSD trials appear
Sign up with your email to follow new studies for NMOSD, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New weapons against devastating nerve attacks
Disease control Not yet recruitingThis study aims to see if new antibody drugs can better control severe flare-ups in people with Neuromyelitis Optica Spectrum Disorder (NMOSD), a rare disease where the immune system attacks nerves and eyes. It will follow about 40 patients in China for 6 months to compare the ef…
Matched conditions: NMOSD
Sponsor: First Affiliated Hospital of Chongqing Medical University • Aim: Disease control
Last updated Mar 30, 2026 14:27 UTC
-
Head-to-Head showdown: which drug best prevents debilitating neurological attacks?
Disease control Not yet recruitingThis study aims to find out which of five existing medications works best to prevent relapses in people with neuromyelitis optica spectrum disorder (NMOSD), a rare autoimmune disease that can cause vision loss and paralysis. About 160 adults with a specific antibody will be rando…
Matched conditions: NMOSD
Phase: PHASE4 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
Massive study launches to unlock hormone clues in rare autoimmune disease
Knowledge-focused Not yet recruitingThis study aims to understand how sex hormone levels differ in people with NMOSD compared to healthy individuals. It will follow 4,000 participants in China for three years, collecting blood samples and health data. The goal is to learn if hormone changes are linked to how the di…
Matched conditions: NMOSD
Sponsor: Xiamen Hospital of Traditional Chinese Medicine • Aim: Knowledge-focused
Last updated Feb 23, 2026 14:54 UTC